Join Growin Stock Community!

中湛6236.TW Overview

TW StockOthers
(No presentation for 6236)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

中湛(6236)Overall Performance

中湛(6236)AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

中湛(6236) PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

中湛(6236)Key Information

中湛(6236)Profile

Neith Corporation engages in the biotechnology, medical cosmetics, and preventive medicine businesses. The company offers nutritional products, including L-One, a liquid formula for maintaining eye health; EPlus, a multiple enzyme supplement; and other nutritional products under the King One name. It also provides genetic testing services. In addition, the company offers energy and dual-purpose mattresses, energy masks, energy silicon gel necklaces, energy waistbands, energy heating stones, massage rods, and water purifiers, as well as Ganbanyoku, an energy stone spa bed. Further, it provides beauty care products, such as cell regeneration and rejuvenation series skin care products; home energy products; and microcontrollers and peripherals. The company was formerly known as Come True Biomedical Inc. Neith Corporation was incorporated in 1997 and is headquartered in Taichung, Taiwan.

中湛(6236)FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.09
PE Ratio (TTM)
245.49
Forward PE
-
PS Ratio (TTM)
22.86
PB Ratio
5.81
Price-to-FCF
199.85
METRIC
VALUE
vs. INDUSTRY
Gross Margin
83.60%
Net Margin
9.31%
Revenue Growth (YoY)
-6.55%
Profit Growth (YoY)
21.85%
3-Year Revenue Growth
0.70%
3-Year Profit Growth
29.59%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.09
PE Ratio (TTM)
245.49
Forward PE
-
PS Ratio (TTM)
22.86
PB Ratio
5.81
Price-to-FCF
199.85
Gross Margin
83.60%
Net Margin
9.31%
Revenue Growth (YoY)
-6.55%
Profit Growth (YoY)
21.85%
3-Year Revenue Growth
0.70%
3-Year Profit Growth
29.59%
default symbol

6236

中湛

21.60D

0.00%

(0.00)

  • When is 6236's latest earnings report released?

    The most recent financial report for 中湛 (6236) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6236's short-term business performance and financial health. For the latest updates on 6236's earnings releases, visit this page regularly.

  • Where does 6236 fall in the P/E River chart?

    According to historical valuation range analysis, 中湛 (6236)'s current price-to-earnings (P/E) ratio is 354.04, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 6236?

    According to the latest financial report, 中湛 (6236) reported an Operating Profit of -1.15M with an Operating Margin of -15.34% this period, representing a growth of 72.09% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 6236's revenue growth?

    In the latest financial report, 中湛 (6236) announced revenue of 7.51M, with a Year-Over-Year growth rate of -22.52%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 6236 have?

    At the end of the period, 中湛 (6236) held Total Cash and Cash Equivalents of 138.99M, accounting for 0.83 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 6236 go with three margins increasing?

    In the latest report, 中湛 (6236) did not achieve the “three margins increasing” benchmark, with a gross margin of 81.77%%, operating margin of -15.34%%, and net margin of -10.48%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6236's profit trajectory and future growth potential.

  • Is 6236's EPS continuing to grow?

    According to the past four quarterly reports, 中湛 (6236)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.02. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 6236?

    中湛 (6236)'s Free Cash Flow (FCF) for the period is 660K, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 816.67% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.